NON-INVASIVE BLOOD GLUCOSE MONITOR
PAGE UPDATED 5/16
Integrity Applications, a company based in Ashdod, Israel, develops and markets medical devices - in this case a non-invasive glucose monitoring device for use by people with diabetes. The Gluco Track model DF-F employs a combination of ultrasound, electromagnetic and thermal technologies together with a proprietary algorithm to obtain blood glucose levels without drawing a blood sample. This model received a final approval CE Mark in 2014 which allows the company to market and sell its device in the European Union. It utilizes a small sensor that is clipped to a person’s ear lobe and connected to a hand held monitor display about the size of a smart phone. This will allow Type 2 and those considered to be pre-diabetics to test their BG levels more frequently without the pain associated with needle pricking and reduce cost by the elimination of test strips in the day to day management of the disease. Test results indicate a positive correlation between Gluco Track DF-F readings and those obtained from conventional invasive devices. The unit is expected to undergo clinical trials for US - FDA approval sometime in 2016 once trial protocols have been established.
No mention of costs have been found to date. For further info visit: www.integrity-app.com